Pzena Investment Management LLC Has $36.80 Million Holdings in Varex Imaging $VREX

Key Points

• Pzena Investment Management LLC increased its holdings in Varex Imaging by 11.6%, bringing their total to approximately $36.80 million worth of shares.
• Varex Imaging recently reported an EPS of $0.18, significantly exceeding the consensus estimate of $0.04, with quarterly revenue reaching $203 million.
• Analysts have mixed opinions on Varex Imaging, with two rating it a Buy and one a Sell, while the average price target stands at $19.50.

Pzena Investment Management LLC boosted its stake in shares of Varex Imaging (NASDAQ:VREX - Free Report) by 11.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,244,977 shares of the company's stock after buying an additional 442,628 shares during the period. Pzena Investment Management LLC owned about 10.30% of Varex Imaging worth $36,804,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC grew its stake in Varex Imaging by 0.3% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 2,788,092 shares of the company's stock valued at $23,894,000 after acquiring an additional 8,680 shares in the last quarter. Vanguard Group Inc. grew its stake in Varex Imaging by 4.2% during the 1st quarter. Vanguard Group Inc. now owns 2,640,127 shares of the company's stock valued at $30,625,000 after acquiring an additional 106,412 shares in the last quarter. Cooke & Bieler LP grew its stake in Varex Imaging by 18.7% during the 1st quarter. Cooke & Bieler LP now owns 2,122,683 shares of the company's stock valued at $24,623,000 after acquiring an additional 333,794 shares in the last quarter. Wellington Management Group LLP grew its stake in Varex Imaging by 5.9% during the 1st quarter. Wellington Management Group LLP now owns 1,545,829 shares of the company's stock valued at $17,932,000 after acquiring an additional 86,350 shares in the last quarter. Finally, Royce & Associates LP grew its stake in Varex Imaging by 2.1% during the 1st quarter. Royce & Associates LP now owns 762,733 shares of the company's stock valued at $8,848,000 after acquiring an additional 15,963 shares in the last quarter.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Varex Imaging in a research note on Wednesday, October 8th. Wall Street Zen cut Varex Imaging from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 9th. Finally, B. Riley reaffirmed a "buy" rating and set a $16.00 target price (up previously from $12.00) on shares of Varex Imaging in a research note on Friday, August 8th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $19.50.

Varex Imaging Trading Down 4.3%

Shares of NASDAQ VREX opened at $10.81 on Monday. The stock has a market cap of $448.62 million, a price-to-earnings ratio of -3.37 and a beta of 0.96. The business has a 50 day simple moving average of $11.14 and a 200 day simple moving average of $9.20. Varex Imaging has a 52 week low of $6.76 and a 52 week high of $16.93. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.82 and a current ratio of 3.51.

Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.04 by $0.14. The business had revenue of $203.00 million during the quarter, compared to analysts' expectations of $190.32 million. Varex Imaging had a positive return on equity of 5.54% and a negative net margin of 16.13%. Varex Imaging has set its Q4 2025 guidance at 0.100-0.300 EPS. On average, research analysts predict that Varex Imaging will post 0.53 earnings per share for the current fiscal year.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging (NASDAQ:VREX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.